KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Equity: 2018-2024

Historic Return on Equity for Aquestive Therapeutics (AQST) over the last 7 years, with Dec 2024 value amounting to 0.53%.

  • Aquestive Therapeutics' Return on Equity rose 93.00% to 1.80% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.80%, marking a year-over-year increase of 93.00%. This contributed to the annual value of 0.53% for FY2024, which is 46.00% up from last year.
  • Latest data reveals that Aquestive Therapeutics reported Return on Equity of 0.53% as of FY2024, which was up 657.36% from 0.07% recorded in FY2023.
  • In the past 5 years, Aquestive Therapeutics' Return on Equity ranged from a high of 2.04% in FY2020 and a low of 0.07% during FY2023.
  • Its 3-year average for Return on Equity is 0.38%, with a median of 0.53% in 2024.
  • Per our database at Business Quant, Aquestive Therapeutics' Return on Equity soared by 3,552bps in 2020 and then tumbled by 96bps in 2021.
  • Yearly analysis of 5 years shows Aquestive Therapeutics' Return on Equity stood at 2.04% in 2020, then plummeted by 96bps to 1.08% in 2021, then plummeted by 54bps to 0.54% in 2022, then plummeted by 47bps to 0.07% in 2023, then surged by 46bps to 0.53% in 2024.